TEK2day FINANCE About TEK2day Finance

SI-BONE, Inc. (SIBN)

NGM · Healthcare · Medical Devices

$18.38 +0.44%

Closing price as of 2026-09-11 · Source: TEK2day Finance

1-Year Price History +12.6% over period
$22$19$17$14$11 2025-092025-122026-032026-062026-09

Key Metrics

Market Cap
$823.8M
Shares Outstanding
44.8M
P/S (TTM)
3.9x
Exchange
NGM
Currency
USD

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Quarterly Financials

Metric2025-09-302025-12-312026-03-312026-06-30
Revenue48.7M56.3M52.6M56.0M
Gross Profit38.8M44.5M41.9M44.5M
Operating Income(5.4M)(2.5M)(5.1M)(4.8M)
Net Income(4.6M)(1.6M)(4.3M)(4.1M)
Diluted EPS$-0.11$-0.04$-0.10$-0.09

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue106.4M138.9M167.2M200.9M
Gross Profit90.7M109.4M132.1M159.9M
Operating Income(59.6M)(46.9M)(35.2M)(22.3M)
Net Income(61.3M)(43.3M)(30.9M)(18.9M)
Diluted EPS$-1.79$-1.13$-0.75$-0.44
Want live quotes, estimates, SEC filings, and CEO analytics for SIBN?
The free TEK2day terminal runs in your browser — type /SIBN to get started.
Open SIBN in the Terminal →